(Q28288310)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6269853&resulttype=core&format=json

13 May 2020

0 references

Yongfu Jiang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6269853&resulttype=core&format=json

13 May 2020

Zhiyun Du

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6269853&resulttype=core&format=json

13 May 2020

Guihua Xue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6269853&resulttype=core&format=json

13 May 2020

Qian Chen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6269853&resulttype=core&format=json

13 May 2020

Yujing Lu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6269853&resulttype=core&format=json

13 May 2020

Xi Zheng

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6269853&resulttype=core&format=json

13 May 2020

Allan H Conney

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6269853&resulttype=core&format=json

13 May 2020

Kun Zhang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6269853&resulttype=core&format=json

13 May 2020

language of work or name

English

0 references

publication date

3 April 2013

0 references

published in

Molecules

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6269853&resulttype=core&format=json

13 May 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6269853&resulttype=core&format=json

13 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6269853&resulttype=core&format=json

13 May 2020

page(s)

3948-3961

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6269853&resulttype=core&format=json

Creative Commons Attribution 4.0 International

13 May 2020

copyright license

start time

3 April 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

An updated review of tyrosinase inhibitors

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18043948

Novel tyrosinase inhibitors from natural resources - their computational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18043948

Screening of Chinese herbal medicines for antityrosinase activity in a cell free system and B16 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18043948

The melanogenesis and mechanisms of skin-lightening agents--existing and new approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18043948

The hunt for natural skin whitening agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18043948

Naturally occurring tyrosinase inhibitors: mechanism and applications in skin health, cosmetics and agriculture industries

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18043948

Tyrosinase inhibitors from natural and synthetic sources: structure, inhibition mechanism and perspective for the future.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18043948

(-)-N-Formylanonaine from Michelia alba as a human tyrosinase inhibitor and antioxidant.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18043948

Final report of the safety assessment of Kojic acid as used in cosmetics

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18043948

Skin lightening preparations and the hydroquinone controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18043948

Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18043948

Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18043948

Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18043948

21 January 2018

The targets of curcumin.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18043948

Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa).

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18043948

Curcumin in a model skin lotion formulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18043948

Skin regenerative potentials of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18043948

Curcumin induces heme oxygenase-1 in normal human skin fibroblasts through redox signaling: relevance for anti-aging intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18043948

Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18043948

Synthesis and biological evaluation of curcumin-like diarylpentanoid analogues for anti-inflammatory, antioxidant and anti-tyrosinase activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18043948

Design and synthesis of biphenyl derivatives as mushroom tyrosinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18043948

Synthesis and biological evaluation of novel 4-hydroxybenzaldehyde derivatives as tyrosinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18043948

Crystallographic evidence that the dinuclear copper center of tyrosinase is flexible during catalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES18043948

Identifying melanogenesis inhibitors from Cinnamomum subavenium with in vitro and in vivo screening systems by targeting the human tyrosinase

21 January 2018

1 reference

12 December 2020

Inhibitory effect of hydroxyindoles and their analogues on human melanoma tyrosinase.

1 reference

12 December 2020

Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color

1 reference

12 December 2020

Herbal cocktail as anti-infective: promising therapeutic for the treatment of viral diseases

1 reference

12 December 2020

Inhibition of melanogenesis versus antioxidant properties of essential oil extracted from leaves of Vitex negundo Linn and chemical composition analysis by GC-MS.

1 reference

12 December 2020

Disorders of pigmentation

1 reference

12 December 2020

10.3390/MOLECULES18043948

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6269853&resulttype=core&format=json

release_nb3uvcw7fnfyrf52bnuqmpde54

13 May 2020

Fatcat ID

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6269853&resulttype=core&format=json

13 May 2020

PubMed publication ID

23552906

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6269853&resulttype=core&format=json